Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications - PubMed (original) (raw)
. 2006 Feb 9;49(3):1080-100.
doi: 10.1021/jm050570f.
Affiliations
- PMID: 16451073
- DOI: 10.1021/jm050570f
Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications
Yasuyoshi Iso et al. J Med Chem. 2006.
Abstract
Recent genetic and pharmacological studies have suggested that the metabotropic glutamate receptor subtype 5 (mGluR5) may represent a druggable target in identifying new therapeutics for the treatment of various central nervous system disorders including drug abuse. In particular, considerable attention in the mGluR5 field has been devoted to identifying ligands that bind to the allosteric modulatory site, distinct from the site for the primary agonist glutamate. Both 2-methyl-6-(phenylethynyl)pyridine (MPEP) and its analogue 3-[(2-methyl-4-thiazolyl)ethynyl]pyridine (MTEP) have been shown to be selective and potent noncompetitive antagonists of mGluR5. Because of results presented in this study showing that MTEP prevents the reinstatement of cocaine self-administration caused by the presentation of environmental cues previously associated with cocaine availability, we have prepared a series of analogues of MTEP with the aim of gaining a better understanding of the structural features relevant to its antagonist potency and with the ultimate aim of investigating the effects of such compounds in blunting the self-administration of cocaine. These efforts have led to the identification of compounds showing higher potency as mGluR5 antagonists than either MPEP or MTEP. Two compounds 19 and 59 exhibited functional activity as mGluR5 antagonists that are 490 and 230 times, respectively, better than that of MTEP.
Similar articles
- A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Keck TM, Zou MF, Bi GH, Zhang HY, Wang XF, Yang HJ, Srivastava R, Gardner EL, Xi ZX, Newman AH. Keck TM, et al. Addict Biol. 2014 Mar;19(2):195-209. doi: 10.1111/adb.12086. Epub 2013 Sep 4. Addict Biol. 2014. PMID: 24001208 Free PMC article. - Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM 4th, Movsesyan VA, Faden AI. Lea PM 4th, et al. Br J Pharmacol. 2005 Jun;145(4):527-34. doi: 10.1038/sj.bjp.0706219. Br J Pharmacol. 2005. PMID: 15821750 Free PMC article. - mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD, Ellgren M, Raboisson P. Swedberg MD, et al. J Pharmacol Exp Ther. 2014 Apr;349(1):155-64. doi: 10.1124/jpet.113.211185. Epub 2014 Jan 28. J Pharmacol Exp Ther. 2014. PMID: 24472725 - Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
Lea PM 4th, Faden AI. Lea PM 4th, et al. CNS Drug Rev. 2006 Summer;12(2):149-66. doi: 10.1111/j.1527-3458.2006.00149.x. CNS Drug Rev. 2006. PMID: 16958988 Free PMC article. Review. - Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window.
Mihov Y, Hasler G. Mihov Y, et al. Int J Neuropsychopharmacol. 2016 Jul 5;19(7):pyw002. doi: 10.1093/ijnp/pyw002. Print 2016 Jul. Int J Neuropsychopharmacol. 2016. PMID: 26802568 Free PMC article. Review.
Cited by
- Synthesis and Evaluation of Metabotropic Glutamate Receptor Subtype 5 Antagonists Based on Fenobam().
Gichinga MG, Olson JP, Butala E, Navarro HA, Gilmour BP, Mascarella SW, Carroll FI. Gichinga MG, et al. ACS Med Chem Lett. 2011 Dec 8;2(12):882-884. doi: 10.1021/ml200162f. Epub 2011 Oct 5. ACS Med Chem Lett. 2011. PMID: 22523618 Free PMC article. - Metabotropic glutamate receptor ligands as potential therapeutics for addiction.
Olive MF. Olive MF. Curr Drug Abuse Rev. 2009 Jan;2(1):83-98. doi: 10.2174/1874473710902010083. Curr Drug Abuse Rev. 2009. PMID: 19630739 Free PMC article. Review. - Role of cues and contexts on drug-seeking behaviour.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Perry CJ, et al. Br J Pharmacol. 2014 Oct;171(20):4636-72. doi: 10.1111/bph.12735. Epub 2014 Jul 2. Br J Pharmacol. 2014. PMID: 24749941 Free PMC article. Review. - Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration.
Ben-Shahar O, Sacramento AD, Miller BW, Webb SM, Wroten MG, Silva HE, Caruana AL, Gordon EJ, Ploense KL, Ditzhazy J, Kippin TE, Szumlinski KK. Ben-Shahar O, et al. J Neurosci. 2013 Jan 9;33(2):495-506a. doi: 10.1523/JNEUROSCI.3710-12.2013. J Neurosci. 2013. PMID: 23303930 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical